Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 126,173 | 110,792 | 95,306 | 87,869 | 71,870 |
| Cost of Goods | 9,129 | 7,163 | 6,751 | 6,788 | 5,850 |
| Gross Profit | 117,044 | 103,629 | 88,555 | 81,081 | 66,020 |
| Operating Expenses | 146,886 | 150,971 | 137,698 | 129,281 | 122,499 |
| Operating Income | -29,713 | -47,179 | -48,392 | -47,412 | -55,629 |
| Other Income | 5,498 | 4,530 | 4,349 | 3,386 | 2,122 |
| Pre-tax Income | -24,215 | -42,649 | -44,043 | -44,026 | -53,507 |
| Income Tax | 43 | 135 | 10 | N/A | 1 |
| Net Income Continuous | -24,258 | -42,784 | -44,053 | -44,026 | -53,508 |
| Net Income | $-24,258 | $-42,784 | $-44,053 | $-44,026 | $-53,508 |
| EPS Basic Total Ops | -0.25 | -0.45 | -0.46 | -0.45 | -0.57 |
| EPS Basic Continuous Ops | -0.25 | -0.45 | -0.46 | -0.46 | -0.57 |
| EPS Diluted Total Ops | -0.25 | -0.45 | -0.46 | -0.45 | -0.57 |
| EPS Diluted Continuous Ops | -0.25 | -0.45 | -0.46 | -0.46 | -0.57 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.45 | -0.46 | N/A | N/A |
| EBITDA(a) | $-31,769 | $-48,989 | $-49,995 | $-46,105 | $-55,229 |